VACCINOGEN

Vaccinogen is a biotechnology company that produces personalized vaccines that use the patient's immune system to fight the disease... Vaccinogen is an industry leading patient-specific immunotherapy company with Phase III data demonstrating that OncoVAX® reduces Stage 2 colon cancer recurrence from one in three patients to one in nine. Vaccinogen expects to begin enrolling patients in an international Phase IIIb confirmatory study (ACTIVE) in a larger group of patients who will receive patient-specific OncoVAX® doses processed with a patented, proprietary process.

Also known as: Vaccinogen, Inc.

Primary location: Savannah United States